Stay updated with breaking news from Kronos Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it...
In this article we will check out the progression of hedge fund sentiment towards Brookdale Senior Living, Inc. (NYSE:BKD) and determine whether it is a good investment right now.
Stablix Therapeutics launches today with a $63 million series A to bankroll work on protein stabilization in the hopes of treating rare diseases, cancer and immunological disorders.
Kronos Bio Announces Participation in Bank of America Securities 2021 Health Care Conference May 06, 2021 08:00 ET | Source: Kronos Bio, Inc. Kronos Bio, Inc. San Mateo, California, UNITED STATES SAN MATEO, Calif. and CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that members of the management team will participate in a fireside chat at the Bank of America Securities 2021 Health Care Conference on Thursday, May 13, 2021 ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained ... Kronos Bio, Inc.April 10, 2021 GMT MYC genomic amplification found to be a key driver of sensitivity to CDK9 inhibition Pan-cancer anti-tumor activity, including in tumors exposed to prior lines of therapy, seen with intermittent dosing of KB-0742 Initial safety, pharmacokinetic and pharmacodynamic data from the ongoing Phase 1/2 clinical trial for KB-0742 expected in fourth quarter of 2021 SAN MATEO, ...